SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2184328

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2184328

Atopic Dermatitis Therapeutics Market, By Drug Class, By Route of Administration, By Severity, By Distribution Channel, By Geography

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Atopic Dermatitis Therapeutics Market is estimated to be valued at USD 20.74 Bn in 2026 and is expected to reach USD 35.89 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.2% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 20.74 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 8.20% 2033 Value Projection: USD 35.89 Bn

Atopic dermatitis (AD), commonly referred to as eczema, is a chronic, relapsing inflammatory skin disease, characterized by severe pruritus, erythema and altered skin-barrier function. It can affect all age groups and is caused by a complicated interaction between genetic predisposition, immune dysregulation and environmental triggers, with Th2-mediated inflammation being a key player. Atopic dermatitis imposes a considerable burden on mental health and quality of life, including sleep disturbances, anxiety and depression.

The global atopic dermatitis therapeutics market consists of topical corticosteroids, calcineurin inhibitors, biologics, JAK inhibitors and emerging targeted treatments. Rising disease prevalence, particularly among pediatric populations, along with advances in targeted immunotherapies and expanding treatment options for moderate-to-severe disease, is reshaping the therapeutic landscape and supporting market growth.

Market Dynamics

The global atopic dermatitis therapeutics market is driven by the rising prevalence of atopic dermatitis, the increasing need for effective treatment options, and the transition from traditional therapies to targeted biologics and small molecule drugs. The market growth is also fueled by the use of therapies such as dupilumab, upadacitinib and abrocitinib along with rising healthcare awareness, disposable incomes and dermatology infrastructure in emerging markets.

However, the growth of atopic dermatitis therapeutics market is limited by factors such as high cost of advanced therapies, limited access in low- and middle-income countries, stringent regulatory requirements and safety concerns associated with systemic therapies and JAK inhibitor. Nevertheless, significant opportunities exist in the next generation therapies targeting pathways such as IL-31 and IL-33 (in development) and OX40/OX40L and TSLP (available). Increasing interest in precision medicine and patient stratification based on biomarkers, expanding digital dermatology and telemedicine platforms can further improve diagnosis and treatment access, particularly across underserved markets, while enabling broader adoption of advanced therapeutics.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global atopic dermatitis therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Sanofi, Regeneron Pharmaceuticals, Inc., AbbVie Inc., Eli Lilly and Company, LEO Pharma A/S, Pfizer Inc., Incyte Corporation, Amgen Inc., Almirall, S.A., and Galderma S.A.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global atopic dermatitis therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global atopic dermatitis therapeutics market

Market Segmentation

  • Drug Class Insights (Revenue, USD Bn, 2021 - 2033)
  • Biologics
  • Corticosteroids
  • Calcineurin Inhibitors
  • PDE-4 Inhibitors
  • JAK Inhibitors
  • Others
  • Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
  • Topical
  • Oral
  • Injectable
  • Severity Insights (Revenue, USD Bn, 2021 - 2033)
  • Mild
  • Moderate
  • Severe
  • Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Sanofi
  • Regeneron Pharmaceuticals, Inc.
  • AbbVie Inc.
  • Eli Lilly and Company
  • LEO Pharma A/S
  • Pfizer Inc.
  • Incyte Corporation
  • Amgen Inc.
  • Almirall, S.A.
  • Galderma S.A.
Product Code: CMI10235

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Atopic Dermatitis Therapeutics Market, By Drug Class
    • Global Atopic Dermatitis Therapeutics Market, By Route of Administration
    • Global Atopic Dermatitis Therapeutics Market, By Severity
    • Global Atopic Dermatitis Therapeutics Market, By Distribution Channel
    • Global Atopic Dermatitis Therapeutics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Drug Class Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Industry Trends

4. Global Atopic Dermatitis Therapeutics Market, By Drug Class, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Biologics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Calcineurin Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • PDE-4 Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • JAK Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Atopic Dermatitis Therapeutics Market, By Route of Administration, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Atopic Dermatitis Therapeutics Market, By Severity, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Mild
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Moderate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Severe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Atopic Dermatitis Therapeutics Market, By Distribution Channel, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Atopic Dermatitis Therapeutics Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Severity, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Severity, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Severity, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Severity, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Severity, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Severity, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Regeneron Pharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Eli Lilly and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • LEO Pharma A/S
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Incyte Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Almirall, S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Galderma S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!